Global health authorities have issued a stark warning: travelers should avoid nonessential trips to four African nations—Democratic Republic of Congo, South Sudan, Uganda, and Rwanda—due to escalating risks of Ebola virus disease. The U.S. Centers for Disease Control and Prevention (CDC) raised its travel alert to Level 3: Reconsider Travel for these countries, citing active outbreaks, limited healthcare infrastructure, and the potential for rapid transmission. This advisory, effective as of May 19, 2026, underscores the urgency of the situation as public health officials brace for possible regional spread.
The CDC’s decision follows confirmed Ebola cases in multiple regions, including North Kivu and Ituri provinces in Congo, where health workers have reported clusters of infections linked to recent contact with infected individuals and wildlife reservoirs. In Rwanda, the alert reflects proximity to affected areas and the country’s role as a transit hub for travelers moving between East African nations. The World Health Organization (WHO) has similarly escalated its response, deploying emergency teams to support vaccination campaigns and contact tracing in high-risk zones.
For travelers already in these regions, the CDC advises avoiding contact with sick or deceased individuals, practicing rigorous hand hygiene, and seeking immediate medical care if symptoms—such as fever, muscle pain, or unexplained bleeding—emerge. The advisory does not impose travel bans but serves as a critical precaution for those assessing risk. Below, we break down the current status by country, the science behind Ebola’s transmission, and what the alert means for global health security.
Why the Alert? Understanding Ebola’s Current Threat
Ebola virus disease remains one of the most lethal infectious diseases known, with fatality rates exceeding 60% in some outbreaks, according to the CDC. Transmission occurs through direct contact with bodily fluids of infected persons or animals, or with contaminated surfaces. The current outbreaks in Congo and Uganda are attributed to the Zaire ebolavirus strain, the most virulent of the five known Ebola species.
Key factors driving the CDC’s heightened alert include:
- Active transmission chains: As of May 2026, the DRC’s health ministry has confirmed over 120 cases in North Kivu since January, with 78 deaths. Uganda’s first cases in 2026 were linked to a cross-border spillover from Congo.
- Healthcare strain: Weakened healthcare systems in South Sudan and parts of Congo struggle to contain outbreaks, increasing the risk of nosocomial (hospital-acquired) transmission.
- Regional connectivity: Rwanda’s proximity to Congo and its status as a regional transport hub elevate its vulnerability to imported cases.
The WHO’s emergency committee met on May 18, 2026, and declared the situation a Public Health Emergency of International Concern (PHEIC), a designation reserved for events posing a global threat. This triggers coordinated international responses, including vaccine distribution and logistical support from organizations like Médecins Sans Frontières (MSF).
Country-Specific Risks: What Travelers Need to Know
The CDC’s Level 3 alert applies to all four nations, but the risks vary by location, and context. Below is a breakdown of the current situation:

| Country | Current Status | Key Risks | CDC Advisory Level |
|---|---|---|---|
| Democratic Republic of Congo | Active outbreaks in North Kivu and Ituri provinces; 120+ confirmed cases since January 2026. | High transmission in rural health posts; limited vaccine access in conflict zones. | Level 3: Reconsider Travel |
| South Sudan | No confirmed cases in 2026, but historical outbreaks and porous borders with Congo. | Weak surveillance; potential for undetected spillover. | Level 3: Reconsider Travel |
| Uganda | First 2026 cases confirmed in March; linked to cross-border movement from Congo. | Urban centers like Kampala at risk due to travel links. | Level 3: Reconsider Travel |
| Rwanda | No confirmed cases, but elevated alert due to proximity and regional travel routes. | Kigali International Airport serves as a hub for East African travelers. | Level 3: Reconsider Travel |
Note: The CDC’s Level 3 advisory means travelers should reconsider nonessential trips but does not prohibit travel outright. Essential workers (e.g., humanitarian aid staff) may proceed with enhanced precautions, including vaccination where available.
Ebola 101: Transmission, Symptoms, and Prevention
Understanding how Ebola spreads is critical to mitigating risk. The virus is not airborne but requires close contact with infected bodily fluids—such as blood, saliva, or sweat—to transmit. Common routes include:
- Direct contact: Touching an infected person’s fluids or contaminated surfaces (e.g., bedding, needles).
- Indirect contact: Handling items (like clothing) used by an infected individual without proper protective gear.
- Animal reservoirs: Fruit bats in Central Africa are the primary carriers; bushmeat consumption can also pose risks.
Symptoms typically appear 2–21 days after exposure and include:
- Sudden fever
- Severe headache and muscle pain
- Vomiting, diarrhea, and stomach pain
- Unexplained bleeding (from eyes, gums, or nose) in later stages
Prevention focuses on barrier precautions, including:
- Hand hygiene: Frequent washing with soap and water or using alcohol-based sanitizers.
- Avoiding contact: No physical contact with sick or deceased individuals.
- Safe food practices: Avoiding bushmeat and consuming only thoroughly cooked food.
- Vaccination: The Ervebo vaccine (developed by Merck) is available in outbreak zones and recommended for high-risk groups.
What This Means for Global Health and Travel
The CDC’s alert reflects broader concerns about Ebola’s potential to disrupt regional stability and global health security. Here’s what stakeholders are watching:
- Regional cooperation: The East African Community (EAC) has activated cross-border surveillance teams to monitor movement between Congo, Uganda, Rwanda, and South Sudan.
- Vaccine rollout: The WHO reports that over 500,000 doses of Ervebo have been deployed, but distribution challenges persist in conflict-affected areas.
- Economic impact: Tourism-dependent nations like Rwanda and Uganda face potential losses, though officials emphasize that the alert targets nonessential travel rather than imposing bans.
- Scientific monitoring: Genomic sequencing of recent outbreaks indicates the Zaire ebolavirus strain remains dominant, with no evidence of mutation to increase transmissibility.
For businesses and organizations with operations in the region, the CDC recommends:
- Implementing workplace infection control plans, including training on Ebola symptoms and reporting protocols.
- Ensuring emergency medical evacuation plans are in place for staff in high-risk zones.
- Monitoring updates from the CDC’s travel health notices and the WHO’s Ebola response page.
Key Takeaways: What You Need to Remember
- The CDC’s Level 3 alert advises against nonessential travel to Congo, South Sudan, Uganda, and Rwanda due to Ebola risks.
- Transmission requires close contact with infected fluids; airborne spread is not a concern.
- Symptoms include fever, bleeding, and severe pain—seek medical care immediately if experienced.
- Vaccination is available in outbreak zones for high-risk individuals.
- Regional health teams are scaling up surveillance and vaccine distribution, but challenges remain.
Next Steps: What to Watch For
The situation remains fluid, with the next critical checkpoints including:

- WHO Emergency Committee meeting: Scheduled for June 2, 2026, to reassess the PHEIC designation based on new data.
- CDC travel health updates: Regular revisions expected as outbreak dynamics evolve (subscribe here).
- Vaccine coverage expansion: Targeting 80% of high-risk populations in Congo and Uganda by June 2026.
For travelers or organizations assessing risk, the CDC’s interactive travel health notice provides real-time guidance. If you have concerns about travel plans or workplace safety, share your questions in the comments below—or connect with our team for a personalized risk assessment.
Keep reading